Nifty
Sensex
:
:
11844.10
39434.72
187.05 (1.60%)
623.33 (1.61%)

Pharmaceuticals & Drugs

Rating :
69/99  (View)

BSE: 524804 | NSE: AUROPHARMA

680.65
8.50 (1.26%)
24-May-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  675.00
  •  684.55
  •  671.75
  •  672.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1385499
  •  9430.40
  •  838.00
  •  527.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 39,312.01
  • 17.03
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 42,820.33
  • 0.37%
  • 2.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.87%
  • 2.89%
  • 8.56%
  • FII
  • DII
  • Others
  • 0.05%
  • 13.64%
  • 22.99%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.26
  • 15.24
  • 6.07

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 30.30
  • 12.07
  • 3.42

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 47.02
  • 15.59
  • 6.14

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.09
  • 19.18
  • 18.10

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.04
  • 5.22
  • 4.10

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.02
  • 13.30
  • 12.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
5,269.67
4,336.11
21.53%
4,751.40
4,435.89
7.11%
4,250.27
3,678.75
15.54%
4,049.09
3,641.63
11.19%
Expenses
4,183.29
3,310.53
26.36%
3,765.13
3,319.01
13.44%
3,539.21
2,844.81
24.41%
3,260.98
2,920.39
11.66%
EBITDA
1,086.38
1,025.58
5.93%
986.27
1,116.88
-11.69%
711.06
833.94
-14.73%
788.11
721.24
9.27%
EBIDTM
20.62%
23.65%
20.76%
25.18%
16.73%
22.67%
19.46%
19.81%
Other Income
63.85
33.05
93.19%
26.26
10.27
155.70%
43.73
22.09
97.96%
43.83
40.78
7.48%
Interest
47.65
18.86
152.65%
35.39
17.27
104.92%
29.54
16.87
75.10%
24.72
14.28
73.11%
Depreciation
163.12
138.08
18.13%
163.68
132.08
23.92%
154.53
131.18
17.80%
156.63
100.05
56.55%
PBT
914.42
901.69
1.41%
786.62
977.80
-19.55%
570.72
707.98
-19.39%
650.59
647.69
0.45%
Tax
204.78
306.94
-33.28%
175.42
197.96
-11.39%
115.54
190.99
-39.50%
122.39
117.15
4.47%
PAT
709.64
594.75
19.32%
611.20
779.84
-21.62%
455.18
516.99
-11.96%
528.20
530.54
-0.44%
PATM
13.47%
13.72%
12.86%
17.58%
10.71%
14.05%
13.04%
14.57%
EPS
12.16
10.16
19.69%
10.44
13.33
-21.68%
7.78
8.85
-12.09%
9.02
9.09
-0.77%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
18,320.43
16,463.03
14,909.54
13,794.65
12,120.52
8,099.79
5,855.32
4,627.40
4,381.48
3,575.44
3,077.28
Net Sales Growth
13.85%
10.42%
8.08%
13.81%
49.64%
38.33%
26.54%
5.61%
22.54%
16.19%
 
Cost Of Goods Sold
8,009.49
6,162.23
5,911.00
5,612.30
5,099.89
3,275.54
2,730.00
2,303.99
1,963.83
1,574.54
1,533.07
Gross Profit
10,310.94
10,300.80
8,998.54
8,182.35
7,020.63
4,824.25
3,125.32
2,323.41
2,417.65
2,000.90
1,544.21
GP Margin
56.28%
62.57%
60.35%
59.32%
57.92%
59.56%
53.38%
50.21%
55.18%
55.96%
50.18%
Total Expenditure
14,748.61
12,691.28
11,475.26
10,606.53
9,556.90
5,966.14
4,994.37
4,066.10
3,418.22
2,752.25
2,809.89
Power & Fuel Cost
-
470.95
437.14
419.26
359.60
349.84
324.72
232.36
208.26
194.91
182.72
% Of Sales
-
2.86%
2.93%
3.04%
2.97%
4.32%
5.55%
5.02%
4.75%
5.45%
5.94%
Employee Cost
-
2,130.84
1,767.76
1,542.62
1,302.26
802.43
663.31
535.69
425.07
324.13
240.89
% Of Sales
-
12.94%
11.86%
11.18%
10.74%
9.91%
11.33%
11.58%
9.70%
9.07%
7.83%
Manufacturing Exp.
-
1,534.44
1,309.64
1,256.18
1,022.70
772.04
623.04
543.16
511.60
349.01
268.67
% Of Sales
-
9.32%
8.78%
9.11%
8.44%
9.53%
10.64%
11.74%
11.68%
9.76%
8.73%
General & Admin Exp.
-
1,068.21
997.32
686.38
666.38
283.49
197.83
130.74
120.34
116.94
104.63
% Of Sales
-
6.49%
6.69%
4.98%
5.50%
3.50%
3.38%
2.83%
2.75%
3.27%
3.40%
Selling & Distn. Exp.
-
1,025.85
848.43
901.87
878.98
359.60
305.98
208.20
141.59
143.56
152.87
% Of Sales
-
6.23%
5.69%
6.54%
7.25%
4.44%
5.23%
4.50%
3.23%
4.02%
4.97%
Miscellaneous Exp.
-
298.76
203.97
187.92
227.09
123.20
149.49
111.96
47.53
49.16
152.87
% Of Sales
-
1.81%
1.37%
1.36%
1.87%
1.52%
2.55%
2.42%
1.08%
1.37%
10.63%
EBITDA
3,571.82
3,771.75
3,434.28
3,188.12
2,563.62
2,133.65
860.95
561.30
963.26
823.19
267.39
EBITDA Margin
19.50%
22.91%
23.03%
23.11%
21.15%
26.34%
14.70%
12.13%
21.98%
23.02%
8.69%
Other Income
177.67
101.98
115.89
203.80
96.71
21.56
28.54
24.70
71.41
151.49
26.05
Interest
137.30
77.72
66.72
256.70
159.87
310.16
266.64
277.24
64.65
73.09
93.22
Depreciation
637.96
557.97
427.63
392.37
332.61
312.53
248.74
200.53
171.50
149.34
127.60
PBT
2,922.35
3,238.04
3,055.82
2,742.85
2,167.85
1,532.52
374.11
108.23
798.52
752.25
72.62
Tax
618.13
818.27
759.65
720.71
596.59
363.45
82.71
-88.81
225.12
191.36
21.36
Tax Rate
21.15%
25.27%
24.86%
26.28%
27.52%
23.72%
22.11%
41.70%
28.56%
25.44%
29.41%
PAT
2,304.22
2,420.03
2,296.64
2,023.64
1,575.77
1,172.85
293.86
-123.50
563.45
561.21
51.31
PAT before Minority Interest
2,304.04
2,419.77
2,296.17
2,022.14
1,571.26
1,169.07
291.40
-124.14
563.06
560.89
51.26
Minority Interest
-0.18
0.26
0.47
1.50
4.51
3.78
2.46
0.64
0.39
0.32
0.05
PAT Margin
12.58%
14.70%
15.40%
14.67%
13.00%
14.48%
5.02%
-2.67%
12.86%
15.70%
1.67%
PAT Growth
-4.87%
5.37%
13.49%
28.42%
34.35%
299.12%
337.94%
-121.92%
0.40%
993.76%
 
Unadjusted EPS
39.40
41.36
39.33
34.67
27.03
40.27
10.09
-4.24
19.57
20.81
18.65

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
11,680.42
9,371.91
7,287.30
5,155.91
3,750.15
2,605.76
2,339.65
2,444.83
1,829.08
1,241.26
Share Capital
58.59
58.59
58.52
29.20
29.15
29.12
29.11
29.11
27.86
26.88
Total Reserves
11,621.76
9,313.22
7,227.50
5,126.71
3,721.00
2,576.64
2,310.54
2,415.72
1,801.22
1,214.38
Non-Current Liabilities
583.54
102.07
583.85
1,591.60
1,493.91
1,225.26
967.29
645.49
2,245.74
2,409.84
Secured Loans
26.96
177.59
380.10
773.54
1,101.31
1,084.11
862.08
449.74
864.05
987.67
Unsecured Loans
424.24
3.81
362.71
587.93
178.05
64.15
102.55
73.61
1,290.51
1,345.30
Long Term Provisions
55.86
39.13
23.36
24.35
9.18
9.00
4.24
3.09
0.00
0.00
Current Liabilities
8,680.62
6,605.60
7,840.22
6,136.40
4,220.04
3,430.83
2,915.05
2,768.49
707.99
570.05
Trade Payables
2,627.44
2,154.70
2,457.03
2,051.13
1,351.20
963.75
660.14
776.35
604.40
514.77
Other Current Liabilities
1,777.80
1,286.82
1,577.58
1,364.95
387.68
150.87
580.34
699.09
68.40
28.69
Short Term Borrowings
4,031.34
2,902.72
3,672.68
2,502.08
2,354.56
2,236.12
1,608.21
1,234.73
0.00
0.00
Short Term Provisions
244.04
261.36
132.93
218.24
126.60
80.09
66.36
58.32
35.19
26.59
Total Liabilities
20,946.40
16,081.66
15,713.92
12,909.73
9,489.77
7,272.85
6,232.20
5,867.93
4,787.14
4,224.30
Net Block
6,520.68
4,833.78
4,179.69
3,705.64
2,721.67
2,638.87
2,194.65
1,738.60
1,710.85
1,398.77
Gross Block
7,894.78
5,635.49
4,569.83
5,446.13
4,182.96
3,763.47
3,086.25
2,438.00
2,407.67
1,973.63
Accumulated Depreciation
1,374.10
801.71
390.14
1,740.49
1,461.29
1,124.60
891.60
699.40
696.82
574.86
Non Current Assets
8,758.56
6,875.48
5,419.57
4,610.93
3,858.59
3,136.10
2,968.16
2,546.75
2,280.47
1,934.61
Capital Work in Progress
1,583.04
1,458.08
848.14
370.35
256.67
167.82
515.74
582.86
570.08
536.30
Non Current Investment
311.52
245.85
122.94
0.14
19.76
22.24
19.86
38.49
-0.46
-0.46
Long Term Loans & Adv.
255.76
256.48
236.56
455.27
789.04
237.82
108.12
110.77
0.00
0.00
Other Non Current Assets
87.56
81.29
32.24
30.25
18.40
18.66
0.12
1.47
0.00
0.00
Current Assets
12,187.84
9,206.18
10,294.35
8,298.80
5,631.18
4,136.75
3,264.04
3,321.18
2,506.67
2,289.69
Current Investments
0.02
0.02
0.02
19.65
0.03
0.04
18.68
0.04
0.74
0.72
Inventories
5,858.41
4,330.54
4,056.14
3,611.30
2,367.54
1,923.59
1,545.56
1,455.27
1,102.45
877.63
Sundry Debtors
3,084.36
2,765.33
4,606.68
3,539.17
2,636.57
1,596.98
1,239.96
1,230.98
956.01
889.76
Cash & Bank
1,261.62
513.48
800.26
469.11
178.58
208.45
70.86
186.72
72.83
127.65
Other Current Assets
1,983.43
1,084.72
464.37
271.67
448.46
407.69
388.98
448.17
374.64
393.93
Short Term Loans & Adv.
760.11
512.09
366.88
387.90
237.22
207.51
216.67
358.87
280.60
333.16
Net Current Assets
3,507.22
2,600.58
2,454.13
2,162.40
1,411.14
705.92
348.99
552.69
1,798.68
1,719.64
Total Assets
20,946.40
16,081.66
15,713.92
12,909.73
9,489.77
7,272.85
6,232.20
5,867.93
4,787.14
4,224.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
1,954.82
3,278.58
1,419.76
1,236.81
646.28
274.87
326.25
335.11
425.18
136.03
PBT
3,241.18
3,060.84
2,744.30
2,167.85
1,532.52
374.11
108.23
798.52
752.25
72.62
Adjustment
535.02
408.92
487.50
406.28
515.12
441.54
387.22
197.72
99.77
427.84
Changes in Working Capital
-1,068.98
582.52
-1,079.41
-841.73
-1,057.41
-421.56
-128.34
-469.45
-273.72
-334.21
Cash after chg. in Working capital
2,707.22
4,052.28
2,152.39
1,732.40
990.23
394.09
367.11
526.79
578.30
166.25
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-752.40
-773.70
-732.63
-495.59
-343.95
-119.22
-40.86
-191.68
-153.12
-30.22
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,956.95
-1,787.04
-1,445.21
-1,397.97
-818.74
-246.34
-563.16
-599.07
-399.02
-406.28
Net Fixed Assets
-771.00
-1,092.24
125.11
-533.87
-141.02
-224.46
-376.05
-396.28
-478.66
-288.52
Net Investments
-285.55
-498.60
-170.60
-140.13
-164.64
-78.98
-135.92
-122.17
-101.50
18.54
Others
-900.40
-196.20
-1,399.72
-723.97
-513.08
57.10
-51.19
-80.62
181.14
-136.30
Cash from Financing Activity
864.15
-1,915.26
365.44
93.21
117.64
108.09
118.85
406.98
-84.04
164.99
Net Cash Inflow / Outflow
862.02
-423.72
339.99
-67.95
-54.82
136.62
-118.06
143.02
-57.88
-105.26
Opening Cash & Equivalents
319.63
743.49
403.81
148.02
202.73
65.64
183.71
44.72
102.65
235.68
Closing Cash & Equivalent
1,211.84
319.63
743.50
461.10
148.02
202.73
65.64
183.71
47.19
96.96

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
199.36
159.96
124.50
88.29
64.33
44.74
40.19
41.99
32.83
23.09
ROA
13.07%
14.44%
14.13%
14.03%
13.95%
4.32%
-2.05%
10.57%
12.45%
1.30%
ROE
22.99%
27.57%
32.51%
35.29%
36.79%
11.78%
-5.19%
26.35%
36.54%
4.33%
ROCE
22.72%
24.92%
27.35%
27.18%
27.18%
11.17%
1.25%
19.29%
21.84%
5.07%
Fixed Asset Turnover
2.44
2.96
2.79
2.55
2.08
1.75
1.71
1.85
1.67
1.72
Receivable days
64.70
89.16
106.53
91.84
93.55
86.28
95.44
89.07
92.25
89.57
Inventory Days
112.70
101.43
100.27
88.91
94.82
105.51
115.91
104.17
98.97
96.37
Payable days
71.58
75.73
81.50
67.49
71.06
57.79
64.70
70.79
72.18
71.28
Cash Conversion Cycle
105.81
114.86
125.30
113.25
117.31
134.00
146.65
122.45
119.04
114.66
Total Debt/Equity
0.41
0.36
0.69
0.86
1.01
1.32
1.32
0.99
1.18
1.88
Interest Cover
42.66
46.80
11.69
14.56
5.94
2.40
0.23
13.19
11.29
1.78

News Update


  • USFDA classifies inspection concluded at Aurobindo Pharma's API facilities
    17th May 2019, 09:18 AM

    The company has already submitted its initial response to USFDA

    Read More
  • Aurobindo Pharma recalls 88,600 vials of Lidocaine injections from US market
    20th Apr 2019, 15:54 PM

    Lidocaine HCI injection is a medication used for local or regional anaesthesia to perform certain surgeries and procedures

    Read More
  • Aurobindo Pharma’s arm recalls blood pressure lowering drugs in US market
    1st Apr 2019, 10:07 AM

    The presence of trace amounts of an impurity, N-nitrosodiethylamine found in the API which used to manufacture the product

    Read More
  • Aurobindo Pharma’s arm completes acquisition of marketed portfolio from Spectrum Pharma
    2nd Mar 2019, 12:31 PM

    The acquisition has been completed on March 1, 2019

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.